Ignite Creation Date:
2025-12-24 @ 4:21 PM
Ignite Modification Date:
2026-02-03 @ 11:16 AM
Study NCT ID:
NCT06202066
Status:
SUSPENDED
Last Update Posted:
2025-12-19
First Post:
2023-12-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas
Sponsor:
Roswell Park Cancer Institute
Organization: